Cintas (NASDAQ:CTAS) has built a remarkably consistentBusinessout of unglamorous work: supplying and laundering the uniforms, mats, first-aid kits and safety supplies that keep workplaces running. Its steady,Recurring Revenueshows how a decidedly old-economy service business fits into a technology-dominatedNasdaq100, offering ballast and dependable growth.
Fastenal (NASDAQ:FAST) sells the nuts, bolts and industrial supplies that keep factories and building sites running, and because it delivers them to hundreds of thousands of customers, its sales offer an unusually direct read on the health of the industrial economy. That makes Fastenal …
Ferrovial (NASDAQ:FER) owns stakes in some of the world's most valuable pieces of infrastructure: busy toll roads and major airports that collect fees from millions of travellers. That brings a distinctive kind of asset, long-lived infrastructure with steady, inflation-linked cash flows, into theNasdaq100, offering …
RTX Corp (NYSE: RTX) will place Jill Albertelli at the helm of Pratt & Whitney on Jan. 1, 2027, succeeding Shane Eddy as president. Eddy is retiring from RTX after his tenure leading the aerospace unit.
SunCoke Energy, Inc. (NYSE: SXC) appointed Wendell L. Carter to its board effective immediately. Carter will serve on the Compensation Committee and the Governance Committee. His term falls within the class of directors standing for election at SunCoke Energy’s annual stockholders meeting in 2027. …
Verdera Energy Corp. (OTC: VUECF) will distribute 35,000,000 common shares to eligible enCore shareholders through a planned special distribution, with enCore acting as the selling shareholder. Verdera will receive no proceeds from the distribution or from the conversion ofPreferred Sharesinto the Distribution Shares. The …
The prospectus uses $54.21 per share as an assumed offering price, which would correspond to the sale of 1,567,976 shares under its stated calculation. The company is the seller, and the offering would take place from time to time through Mizuho as sales agent. …
REPLIGEN CORP (NASDAQ: RGEN) will see director Karen A. Dawes retire from its board effective September 30, 2026, after more than two decades of service. Dawes linked the timing to the completion of a successful CEO transition.
Scholar Rock Holding Corp (NASDAQ: SRRK) said ISEMBYLD has received FDA approval for spinal muscular atrophy treatment in adults and children receiving an SMN2-targeted therapy. The approval carries safety-related obligations that management had incorrectly described during the company’s September 14, 2026, investor call.
TAKEDA PHARMACEUTICAL CO LTD (NYSE: TAK) Chief Transformation Officer Duprey Lauren Rusckowski sold 34,535 shares at $18.54 per share. The transaction left Rusckowski with 191,522 shares.